As treatment of B-ALL cells with GCs leads to programmed cell death, increased expression of BCL2 family antiapoptotic proteins (e.g. MCL-1) was another particularly interesting finding in GC-resistant B-ALL blasts [18, 25, 49]. The gene discussed is BCL2; the disease is acute lymphoblastic leukemia.